Vaniprevir Completed Phase 2 Trials for Hepatitis C Virus (HCV) Infection Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00704184 | Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007) | |
NCT00880763 | A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016) |